Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,815
archived clinical trials in
Parkinsons Disease

Pharmacokinetics and Safety Study of LY03003 in Patients With Early-stage Parkinson's Disease
A Randomized, Double-blinded, Multiple Ascending Dose Study in Patients With Early-stage Parkinson's Disease to Evaluate the Pharmacokinetics and Safety of LY03003 Following Intramuscular Injections
Status: Enrolling
Updated:  10/20/2015
Collaborative Neuroscience Network, Inc.
21
mi
from 91732
Long Beach, CA
Pharmacokinetics and Safety Study of LY03003 in Patients With Early-stage Parkinson's Disease
A Randomized, Double-blinded, Multiple Ascending Dose Study in Patients With Early-stage Parkinson's Disease to Evaluate the Pharmacokinetics and Safety of LY03003 Following Intramuscular Injections
Status: Enrolling
Updated: 10/20/2015
Collaborative Neuroscience Network, Inc.
21
mi
from 91732
Long Beach, CA
Click here to add this to my saved trials
Pharmacokinetics and Safety Study of LY03003 in Patients With Early-stage Parkinson's Disease
A Randomized, Double-blinded, Multiple Ascending Dose Study in Patients With Early-stage Parkinson's Disease to Evaluate the Pharmacokinetics and Safety of LY03003 Following Intramuscular Injections
Status: Enrolling
Updated:  10/20/2015
Compass Research LLC
2184
mi
from 91732
Orlando, FL
Pharmacokinetics and Safety Study of LY03003 in Patients With Early-stage Parkinson's Disease
A Randomized, Double-blinded, Multiple Ascending Dose Study in Patients With Early-stage Parkinson's Disease to Evaluate the Pharmacokinetics and Safety of LY03003 Following Intramuscular Injections
Status: Enrolling
Updated: 10/20/2015
Compass Research LLC
2184
mi
from 91732
Orlando, FL
Click here to add this to my saved trials
Pharmacokinetics and Safety Study of LY03003 in Patients With Early-stage Parkinson's Disease
A Randomized, Double-blinded, Multiple Ascending Dose Study in Patients With Early-stage Parkinson's Disease to Evaluate the Pharmacokinetics and Safety of LY03003 Following Intramuscular Injections
Status: Enrolling
Updated:  10/20/2015
West Georgia Sleep Disorders Center and Neurology Associates
1898
mi
from 91732
Douglasville, GA
Pharmacokinetics and Safety Study of LY03003 in Patients With Early-stage Parkinson's Disease
A Randomized, Double-blinded, Multiple Ascending Dose Study in Patients With Early-stage Parkinson's Disease to Evaluate the Pharmacokinetics and Safety of LY03003 Following Intramuscular Injections
Status: Enrolling
Updated: 10/20/2015
West Georgia Sleep Disorders Center and Neurology Associates
1898
mi
from 91732
Douglasville, GA
Click here to add this to my saved trials
Pharmacokinetics and Safety Study of LY03003 in Patients With Early-stage Parkinson's Disease
A Randomized, Double-blinded, Multiple Ascending Dose Study in Patients With Early-stage Parkinson's Disease to Evaluate the Pharmacokinetics and Safety of LY03003 Following Intramuscular Injections
Status: Enrolling
Updated:  10/20/2015
QUEST Research Institute
1956
mi
from 91732
Bingham Farms, MI
Pharmacokinetics and Safety Study of LY03003 in Patients With Early-stage Parkinson's Disease
A Randomized, Double-blinded, Multiple Ascending Dose Study in Patients With Early-stage Parkinson's Disease to Evaluate the Pharmacokinetics and Safety of LY03003 Following Intramuscular Injections
Status: Enrolling
Updated: 10/20/2015
QUEST Research Institute
1956
mi
from 91732
Bingham Farms, MI
Click here to add this to my saved trials
Pharmacokinetics and Safety Study of LY03003 in Patients With Early-stage Parkinson's Disease
A Randomized, Double-blinded, Multiple Ascending Dose Study in Patients With Early-stage Parkinson's Disease to Evaluate the Pharmacokinetics and Safety of LY03003 Following Intramuscular Injections
Status: Enrolling
Updated:  10/20/2015
PRA - CRI Lifetree
2388
mi
from 91732
Marlton, NJ
Pharmacokinetics and Safety Study of LY03003 in Patients With Early-stage Parkinson's Disease
A Randomized, Double-blinded, Multiple Ascending Dose Study in Patients With Early-stage Parkinson's Disease to Evaluate the Pharmacokinetics and Safety of LY03003 Following Intramuscular Injections
Status: Enrolling
Updated: 10/20/2015
PRA - CRI Lifetree
2388
mi
from 91732
Marlton, NJ
Click here to add this to my saved trials
Treatment of Depression in Parkinson's Disease Trial
Treatment of Depression in Patients With Parkinson's Disease
Status: Enrolling
Updated:  10/27/2015
Robert Wood Johnson Medical School
2410
mi
from 91732
New Brunswick, NJ
Treatment of Depression in Parkinson's Disease Trial
Treatment of Depression in Patients With Parkinson's Disease
Status: Enrolling
Updated: 10/27/2015
Robert Wood Johnson Medical School
2410
mi
from 91732
New Brunswick, NJ
Click here to add this to my saved trials
Weight Loss in Parkinson's Disease and Role of Small Bowel Bacterial Overgrowth
Weight Loss in Parkinson's Disease and the Potential Role of Small Bowel Bacterial Overgrowth
Status: Enrolling
Updated:  11/5/2015
Mayo Clinic Arizona
356
mi
from 91732
Scottsdale, AZ
Weight Loss in Parkinson's Disease and Role of Small Bowel Bacterial Overgrowth
Weight Loss in Parkinson's Disease and the Potential Role of Small Bowel Bacterial Overgrowth
Status: Enrolling
Updated: 11/5/2015
Mayo Clinic Arizona
356
mi
from 91732
Scottsdale, AZ
Click here to add this to my saved trials
Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease
Status: Enrolling
Updated:  11/6/2015
The Parkinson's & Movement Disorder Institute
25
mi
from 91732
Fountain Valley, CA
Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease
Status: Enrolling
Updated: 11/6/2015
The Parkinson's & Movement Disorder Institute
25
mi
from 91732
Fountain Valley, CA
Click here to add this to my saved trials
Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease
Status: Enrolling
Updated:  11/6/2015
University of South Florida, Parkinson's Disease and Movement Disorders Center
2136
mi
from 91732
Tampa, FL
Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease
Status: Enrolling
Updated: 11/6/2015
University of South Florida, Parkinson's Disease and Movement Disorders Center
2136
mi
from 91732
Tampa, FL
Click here to add this to my saved trials
Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease
Status: Enrolling
Updated:  11/6/2015
Emory University/ Wesley Woods Health Center
1919
mi
from 91732
Atlanta, GA
Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease
Status: Enrolling
Updated: 11/6/2015
Emory University/ Wesley Woods Health Center
1919
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease
Status: Enrolling
Updated:  11/6/2015
UMDNJ - Robert Wood Johnson Medical School
2410
mi
from 91732
New Brunswick, NJ
Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease
Status: Enrolling
Updated: 11/6/2015
UMDNJ - Robert Wood Johnson Medical School
2410
mi
from 91732
New Brunswick, NJ
Click here to add this to my saved trials
Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease
Status: Enrolling
Updated:  11/6/2015
SUNY Downstate Medical Center
2436
mi
from 91732
Brooklyn, NY
Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease
Status: Enrolling
Updated: 11/6/2015
SUNY Downstate Medical Center
2436
mi
from 91732
Brooklyn, NY
Click here to add this to my saved trials
Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease
Status: Enrolling
Updated:  11/6/2015
Hospital Multimedica
2181
mi
from 91732
Guatemala,
Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease
Status: Enrolling
Updated: 11/6/2015
Hospital Multimedica
2181
mi
from 91732
Guatemala,
Click here to add this to my saved trials
Wearable Movement Sensors for Assessing Motor Impairments and Dyskinesias in Parkinson Disease
Wearable Movement Sensors for Assessing Motor Impairments and Dyskinesias in Parkinson Disease
Status: Enrolling
Updated:  11/9/2015
University of Rochester
2244
mi
from 91732
Rochester, NY
Wearable Movement Sensors for Assessing Motor Impairments and Dyskinesias in Parkinson Disease
Wearable Movement Sensors for Assessing Motor Impairments and Dyskinesias in Parkinson Disease
Status: Enrolling
Updated: 11/9/2015
University of Rochester
2244
mi
from 91732
Rochester, NY
Click here to add this to my saved trials
Acamprosate for Treatment of Compulsive Behaviors and Craving in Parkinson's Disease
Acamprosate for Treatment of Compulsive Behaviors and Craving in Parkinson's Disease
Status: Enrolling
Updated:  11/10/2015
PDCMDC 6550 Fannin, Suite 1801
1357
mi
from 91732
Houston, TX
Acamprosate for Treatment of Compulsive Behaviors and Craving in Parkinson's Disease
Acamprosate for Treatment of Compulsive Behaviors and Craving in Parkinson's Disease
Status: Enrolling
Updated: 11/10/2015
PDCMDC 6550 Fannin, Suite 1801
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
A Pilot Study of a Non-Invasive Neuromodulation Device for Treatment of Parkinson's Disease
A Pilot Study of a Non-Invasive Neuromodulation Device for Treatment of Parkinson's Disease
Status: Enrolling
Updated:  11/30/2015
Duke University Health System
2202
mi
from 91732
Durham, NC
A Pilot Study of a Non-Invasive Neuromodulation Device for Treatment of Parkinson's Disease
A Pilot Study of a Non-Invasive Neuromodulation Device for Treatment of Parkinson's Disease
Status: Enrolling
Updated: 11/30/2015
Duke University Health System
2202
mi
from 91732
Durham, NC
Click here to add this to my saved trials
DBS Under General Anesthesia: Comparison To The Standard Technique
DBS Under General Anesthesia Without Neurophysiology: Initial Experience and Comparison To The Standard Technique
Status: Enrolling
Updated:  12/2/2015
St. Joseph's Hospiatl & Medical Center / Barrow Neurological Institute
342
mi
from 91732
Phoenix, AZ
DBS Under General Anesthesia: Comparison To The Standard Technique
DBS Under General Anesthesia Without Neurophysiology: Initial Experience and Comparison To The Standard Technique
Status: Enrolling
Updated: 12/2/2015
St. Joseph's Hospiatl & Medical Center / Barrow Neurological Institute
342
mi
from 91732
Phoenix, AZ
Click here to add this to my saved trials
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
Status: Enrolling
Updated:  12/4/2015
Information on additional locations involved in this clinical trial contact Chelsea Therapeutics
2104
mi
from 91732
Charlotte, NC
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
Status: Enrolling
Updated: 12/4/2015
Information on additional locations involved in this clinical trial contact Chelsea Therapeutics
2104
mi
from 91732
Charlotte, NC
Click here to add this to my saved trials
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
Status: Enrolling
Updated:  12/4/2015
Wisconsin Institute for Neurology and Sleep Disorders
1729
mi
from 91732
Milwaukee, WI
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
Status: Enrolling
Updated: 12/4/2015
Wisconsin Institute for Neurology and Sleep Disorders
1729
mi
from 91732
Milwaukee, WI
Click here to add this to my saved trials
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
Status: Enrolling
Updated:  12/4/2015
NYU Langone Medical Center
2434
mi
from 91732
New York, NY
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
Status: Enrolling
Updated: 12/4/2015
NYU Langone Medical Center
2434
mi
from 91732
New York, NY
Click here to add this to my saved trials
PD4PD:Partnered Dance for Parkinson Disease
PD4PD:Partnered Dance for Parkinson Disease
Status: Enrolling
Updated:  12/7/2015
Washington University School of Medicine
1570
mi
from 91732
St. Louis, MO
PD4PD:Partnered Dance for Parkinson Disease
PD4PD:Partnered Dance for Parkinson Disease
Status: Enrolling
Updated: 12/7/2015
Washington University School of Medicine
1570
mi
from 91732
St. Louis, MO
Click here to add this to my saved trials
Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension
Norepinephrine Transporter Blockade as a Pathophysiological Biomarker in Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated:  12/10/2015
Beth Israel Deaconess Medical Center (Harvard)
2578
mi
from 91732
Boston, MA
Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension
Norepinephrine Transporter Blockade as a Pathophysiological Biomarker in Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated: 12/10/2015
Beth Israel Deaconess Medical Center (Harvard)
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension
Norepinephrine Transporter Blockade as a Pathophysiological Biomarker in Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated:  12/10/2015
New York University
2433
mi
from 91732
New York, NY
Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension
Norepinephrine Transporter Blockade as a Pathophysiological Biomarker in Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated: 12/10/2015
New York University
2433
mi
from 91732
New York, NY
Click here to add this to my saved trials
Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension
Norepinephrine Transporter Blockade as a Pathophysiological Biomarker in Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated:  12/10/2015
Vanderbilt University
1763
mi
from 91732
Nashville, TN
Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension
Norepinephrine Transporter Blockade as a Pathophysiological Biomarker in Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated: 12/10/2015
Vanderbilt University
1763
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension
Norepinephrine Transporter Blockade as a Pathophysiological Biomarker in Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated:  12/10/2015
The Mayo Clinic
1524
mi
from 91732
Rochester, MN
Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension
Norepinephrine Transporter Blockade as a Pathophysiological Biomarker in Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated: 12/10/2015
The Mayo Clinic
1524
mi
from 91732
Rochester, MN
Click here to add this to my saved trials
Erythromycin in Parkinson's Disease
Erythromycin in Parkinson's Disease: A Pilot Study of Its Effects on Levodopa Pharmacokinetics and Pharmacodynamics
Status: Enrolling
Updated:  12/10/2015
Virginia Commonwealth University Parkinson's Center
2267
mi
from 91732
Richmond, VA
Erythromycin in Parkinson's Disease
Erythromycin in Parkinson's Disease: A Pilot Study of Its Effects on Levodopa Pharmacokinetics and Pharmacodynamics
Status: Enrolling
Updated: 12/10/2015
Virginia Commonwealth University Parkinson's Center
2267
mi
from 91732
Richmond, VA
Click here to add this to my saved trials
A Double Blind Placebo Controlled Trial Evaluating Rasagiline Effects on Cognition in Parkinson's Disease Patients With Mild Cognitive Impairment Receiving Dopaminergic Therapy
A Double Blind Placebo Controlled Trial Evaluating Rasagiline Effects on Cognition in Parkinson's Disease Patients With Mild Cognitive Impairment Receiving Dopaminergic Therapy
Status: Enrolling
Updated:  12/15/2015
Georgetown University Hospital
2281
mi
from 91732
Washington,
A Double Blind Placebo Controlled Trial Evaluating Rasagiline Effects on Cognition in Parkinson's Disease Patients With Mild Cognitive Impairment Receiving Dopaminergic Therapy
A Double Blind Placebo Controlled Trial Evaluating Rasagiline Effects on Cognition in Parkinson's Disease Patients With Mild Cognitive Impairment Receiving Dopaminergic Therapy
Status: Enrolling
Updated: 12/15/2015
Georgetown University Hospital
2281
mi
from 91732
Washington,
Click here to add this to my saved trials
Nilotinib in Cognitively Impaired Parkinson Disease Patients 001
Open Label Dose Escalation of Nilotinib in Cognitively Impaired Parkinson Disease Patients With Elevated Cerebrospinal Fluid and Blood α-Synuclein
Status: Enrolling
Updated:  12/15/2015
MedStar Georgetown University Hospital
2281
mi
from 91732
Washington,
Nilotinib in Cognitively Impaired Parkinson Disease Patients 001
Open Label Dose Escalation of Nilotinib in Cognitively Impaired Parkinson Disease Patients With Elevated Cerebrospinal Fluid and Blood α-Synuclein
Status: Enrolling
Updated: 12/15/2015
MedStar Georgetown University Hospital
2281
mi
from 91732
Washington,
Click here to add this to my saved trials
Imaging Biomarkers of Progression of Mobility Impairment in Parkinson Disease
Imaging Biomarkers of Progression of Mobility Impairment in Parkinson Disease
Status: Enrolling
Updated:  12/23/2015
VA Ann Arbor Healthcare System, Ann Arbor, MI
1926
mi
from 91732
Ann Arbor, MI
Imaging Biomarkers of Progression of Mobility Impairment in Parkinson Disease
Imaging Biomarkers of Progression of Mobility Impairment in Parkinson Disease
Status: Enrolling
Updated: 12/23/2015
VA Ann Arbor Healthcare System, Ann Arbor, MI
1926
mi
from 91732
Ann Arbor, MI
Click here to add this to my saved trials
Mobilaser Study to Help With People Who Are Having Problems With Their Gait
Increasing Mobility in Parkinsonian Patients With Freezing of Gait and Gait Hypokinesia With an Adjustable, Attachable Laser (Mobilaser)
Status: Enrolling
Updated:  12/30/2015
Mayo Clinic Florida
2141
mi
from 91732
Jacksonville, FL
Mobilaser Study to Help With People Who Are Having Problems With Their Gait
Increasing Mobility in Parkinsonian Patients With Freezing of Gait and Gait Hypokinesia With an Adjustable, Attachable Laser (Mobilaser)
Status: Enrolling
Updated: 12/30/2015
Mayo Clinic Florida
2141
mi
from 91732
Jacksonville, FL
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated:  1/4/2016
University of Southern California
11
mi
from 91732
Los Angeles, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated: 1/4/2016
University of Southern California
11
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated:  1/4/2016
Colorado Neurological Institute
815
mi
from 91732
Englewood, CO
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated: 1/4/2016
Colorado Neurological Institute
815
mi
from 91732
Englewood, CO
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated:  1/4/2016
University of Florida Center for Movement Disorders and Neurorestoration
2105
mi
from 91732
Gainesville, FL
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated: 1/4/2016
University of Florida Center for Movement Disorders and Neurorestoration
2105
mi
from 91732
Gainesville, FL
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated:  1/4/2016
Emory University/ Wesley Woods Health Center
1919
mi
from 91732
Atlanta, GA
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated: 1/4/2016
Emory University/ Wesley Woods Health Center
1919
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated:  1/4/2016
Augusta University
2059
mi
from 91732
Augusta, GA
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated: 1/4/2016
Augusta University
2059
mi
from 91732
Augusta, GA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated:  1/4/2016
University of Iowa Hospitals, Movement Disorders Div, Dept of Neurology
1529
mi
from 91732
Iowa City, IA
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated: 1/4/2016
University of Iowa Hospitals, Movement Disorders Div, Dept of Neurology
1529
mi
from 91732
Iowa City, IA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated:  1/4/2016
Michigan State University
1897
mi
from 91732
East Lansing, MI
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated: 1/4/2016
Michigan State University
1897
mi
from 91732
East Lansing, MI
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated:  1/4/2016
Henry Ford West Bloomfield Hospital
1951
mi
from 91732
West Bloomfield, MI
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated: 1/4/2016
Henry Ford West Bloomfield Hospital
1951
mi
from 91732
West Bloomfield, MI
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated:  1/4/2016
Atlantic Neuroscience
2414
mi
from 91732
Summit, NJ
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated: 1/4/2016
Atlantic Neuroscience
2414
mi
from 91732
Summit, NJ
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated:  1/4/2016
University of Rochester
2244
mi
from 91732
Rochester, NY
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated: 1/4/2016
University of Rochester
2244
mi
from 91732
Rochester, NY
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated:  1/4/2016
University of Toledo Medical Center
1932
mi
from 91732
Toledo, OH
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated: 1/4/2016
University of Toledo Medical Center
1932
mi
from 91732
Toledo, OH
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated:  1/4/2016
Movement Disorders Program & The Parkinson's Center of Oregon
828
mi
from 91732
Portland, OR
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated: 1/4/2016
Movement Disorders Program & The Parkinson's Center of Oregon
828
mi
from 91732
Portland, OR
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated:  1/4/2016
University of Pennsylvania, Penn Neurological Institute
2375
mi
from 91732
Philadelphia, PA
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multiple Dose, Parallel Group Study to Evaluate the Pharmacodynamics, Efficacy and Safety of RM-131 Administered to Patients With Parkinson's Disease and Chronic Constipation Dissatisfied With Current Therapy
Status: Enrolling
Updated: 1/4/2016
University of Pennsylvania, Penn Neurological Institute
2375
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
A Trial of Neurocognitive and Supportive Therapy Interventions for Individuals With Parkinson's Disease
A Randomized Controlled Trial of Neurocognitive and Supportive Therapy Interventions for Individuals With Parkinson's Disease
Status: Enrolling
Updated:  1/6/2016
VCU Parkinson's and Movement Disorders Center
2268
mi
from 91732
Richmond, VA
A Trial of Neurocognitive and Supportive Therapy Interventions for Individuals With Parkinson's Disease
A Randomized Controlled Trial of Neurocognitive and Supportive Therapy Interventions for Individuals With Parkinson's Disease
Status: Enrolling
Updated: 1/6/2016
VCU Parkinson's and Movement Disorders Center
2268
mi
from 91732
Richmond, VA
Click here to add this to my saved trials
Computer-based Cognitive Training for Individuals With Parkinson's Disease
Computer-based Cognitive Training for Individuals With Parkinson's Disease
Status: Enrolling
Updated:  1/6/2016
Virginia Commonwealth University Parkinson's and Movement Disorders Center
2267
mi
from 91732
Richmond, VA
Computer-based Cognitive Training for Individuals With Parkinson's Disease
Computer-based Cognitive Training for Individuals With Parkinson's Disease
Status: Enrolling
Updated: 1/6/2016
Virginia Commonwealth University Parkinson's and Movement Disorders Center
2267
mi
from 91732
Richmond, VA
Click here to add this to my saved trials
Robust Evaluation to Measure Improvements in Nonadherence From Low-cost Devices
Assessing the Impact of Low-Touch Devices on Medication Adherence
Status: Enrolling
Updated:  1/7/2016
CVS Health
2556
mi
from 91732
Woonsocket, RI
Robust Evaluation to Measure Improvements in Nonadherence From Low-cost Devices
Assessing the Impact of Low-Touch Devices on Medication Adherence
Status: Enrolling
Updated: 1/7/2016
CVS Health
2556
mi
from 91732
Woonsocket, RI
Click here to add this to my saved trials
Deep Brain Stimulation of the Subthalamic Nucleus (STN) and Cognitive Control
Deep Brain Stimulation of the STN and Cognitive Control: A Pilot Study
Status: Enrolling
Updated:  1/7/2016
Washington University School of Medicine
1570
mi
from 91732
St. Louis, MO
Deep Brain Stimulation of the Subthalamic Nucleus (STN) and Cognitive Control
Deep Brain Stimulation of the STN and Cognitive Control: A Pilot Study
Status: Enrolling
Updated: 1/7/2016
Washington University School of Medicine
1570
mi
from 91732
St. Louis, MO
Click here to add this to my saved trials
Development of a Face Valid Executive Functioning Task
Development of a Face Valid Executive Functioning Task
Status: Enrolling
Updated:  1/7/2016
Washington University School of Medicine
1570
mi
from 91732
St. Louis, MO
Development of a Face Valid Executive Functioning Task
Development of a Face Valid Executive Functioning Task
Status: Enrolling
Updated: 1/7/2016
Washington University School of Medicine
1570
mi
from 91732
St. Louis, MO
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel for the Treatment of Non-motor Symptoms in Subjects With Advanced Parkinson's Disease
An Open-Label, Two Part, Multicenter Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel (LCIG) for the Treatment of Non-Motor Symptoms in Subjects With Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
2312
mi
from 91732
Boca Raton, FL
A Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel for the Treatment of Non-motor Symptoms in Subjects With Advanced Parkinson's Disease
An Open-Label, Two Part, Multicenter Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel (LCIG) for the Treatment of Non-Motor Symptoms in Subjects With Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
2312
mi
from 91732
Boca Raton, FL
Click here to add this to my saved trials
A Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel for the Treatment of Non-motor Symptoms in Subjects With Advanced Parkinson's Disease
An Open-Label, Two Part, Multicenter Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel (LCIG) for the Treatment of Non-Motor Symptoms in Subjects With Advanced Parkinson's Disease
Status: Enrolling
Updated:  1/8/2016
Clinical Research Facility
1339
mi
from 91732
Kansas City, KA
A Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel for the Treatment of Non-motor Symptoms in Subjects With Advanced Parkinson's Disease
An Open-Label, Two Part, Multicenter Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel (LCIG) for the Treatment of Non-Motor Symptoms in Subjects With Advanced Parkinson's Disease
Status: Enrolling
Updated: 1/8/2016
Clinical Research Facility
1339
mi
from 91732
Kansas City, KA
Click here to add this to my saved trials